| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $139K | -53.4% |
| Cost of Revenue | $0 | — |
| R&D Expense | $52.8M | -4.1% |
| SG&A Expense | $48.1M | +48.7% |
| Operating Income | -$100.8M | -15.7% |
| Interest Expense | $2.8M | +246.6% |
| Net Income | -$101.9M | -16.2% |
| EPS (Basic) | -$0.62 | -3.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.3M | -27.7% |
| Short-term Investments | $92.0M | +305.7% |
| Accounts Receivable | $28K | +100.0% |
| Current Assets | $140.9M | +58.4% |
| Total Assets | $194.3M | +41.9% |
| Current Liabilities | $23.2M | +4.7% |
| Long-term Debt | $48.6M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$88.9M | -2.1% |
| Capital Expenditures | $1.3M | +8.6% |
| Investing Cash Flow | -$71.1M | -3468.6% |
| Financing Cash Flow | $142.2M | +526.2% |
| Free Cash Flow | -$90.2M | -2.2% |
| Total Liabilities |
| $77.2M |
| +231.0% |
| Stockholders' Equity | $117.1M | +3.1% |